Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
Saved in:
| Date: | 2021 |
|---|---|
| Main Authors: | M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova |
| Format: | Article |
| Language: | English |
| Published: |
2021
|
| Series: | Reports of the National Academy of Sciences of Ukraine |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001260051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016)
by: A. Sahu, et al.
Published: (2016)
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases
by: A. M. Urbanovych
Published: (2015)
by: A. M. Urbanovych
Published: (2015)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Cerebrovascular insufficiency and diabetic encephalopathy in patients with type 2 diabetes mellitus
by: Tovazhnyanska, E.L., et al.
Published: (2014)
by: Tovazhnyanska, E.L., et al.
Published: (2014)
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)
by: T. S. Vatseba, et al.
Published: (2020)
Intra-abdominal hypertension in patients with diabetic ketoacidosis
by: V. Y. Lysenko, et al.
Published: (2014)
by: V. Y. Lysenko, et al.
Published: (2014)
Characteristics of Endothelial dysfunction in patients with Diabetes mellitus
by: A. S. Kuznetsova, et al.
Published: (2018)
by: A. S. Kuznetsova, et al.
Published: (2018)
Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Endothelial dysfunction and cerebrovascular pathology in patients with diabetes mellitus
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
by: E. L. Tovazhnjanskaja, et al.
Published: (2014)
Evaluation of Interleukins and Biochemical Markers Levels Among COVID-19 Iraqi Patients
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
Vitamin D in the complex treatment of diabetes type 2 patients
by: A. S. Yefimov, et al.
Published: (2014)
by: A. S. Yefimov, et al.
Published: (2014)
Cerebrovascular disorders in patients with COVID-19
by: Yu. V. Shmatko, et al.
Published: (2021)
by: Yu. V. Shmatko, et al.
Published: (2021)
Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
by: O. Bondarenko, et al.
Published: (2016)
by: O. Bondarenko, et al.
Published: (2016)
The peculiarities of management of the patients with arterial hypertension in combination with diabetes mellitus
by: A. N. Korzh
Published: (2012)
by: A. N. Korzh
Published: (2012)
State of lipid peroxidation in patients with diabetes mellitus and erectile dysfunction
by: R. S. Rzaev
Published: (2021)
by: R. S. Rzaev
Published: (2021)
Hyperbaric oxigenation regimes in the complex treatment of patients with diabetic foot
by: Yaneva, M.K., et al.
Published: (2007)
by: Yaneva, M.K., et al.
Published: (2007)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Information Technology for Supporting Self-Control in the Formation of a Rational Lifestyle for Diabetics Patients
by: S. I. Kiforenko, et al.
Published: (2019)
by: S. I. Kiforenko, et al.
Published: (2019)
Specificity of perception and emotions in patients with schizophrenia with diabetes mellitus type 2
by: Ye. V. Opria
Published: (2018)
by: Ye. V. Opria
Published: (2018)
Echographic markers of vascular and cardiac disorders in patients with arterial hypertension and arterial hypertension associated with type 2 diabetes mellitus
by: Ya. K. Radzishevska
Published: (2015)
by: Ya. K. Radzishevska
Published: (2015)
Alternative treatment method of diabetes mellitus patients with vast and lastingly nonhealing wounds
by: N. N. Militsa, et al.
Published: (2008)
by: N. N. Militsa, et al.
Published: (2008)
Immunoglobulin isotypes and blood monocyte subpopulations in COVID-19 female patients with different disease severity
by: K. Rebenko, et al.
Published: (2022)
by: K. Rebenko, et al.
Published: (2022)
A correlation between the renal functional reserve and glomerular filtration rate in patients with type 2 diabetes
by: E. S. Kuznetsova, et al.
Published: (2015)
by: E. S. Kuznetsova, et al.
Published: (2015)
A correlation between the renal functional reserve and glomerular filtration rate in patients with type 2 diabetes
by: Kuznetsova, E.S., et al.
Published: (2015)
by: Kuznetsova, E.S., et al.
Published: (2015)
Method of diagnosis nonalcoholic fatty liver in patients with type 2 diabetes mellitus
by: K. Kvit, et al.
Published: (2017)
by: K. Kvit, et al.
Published: (2017)
Q192R polymorphism of PON-1 gene in type 2 diabetic patients
by: Ju. Gorshunskaja, et al.
Published: (2011)
by: Ju. Gorshunskaja, et al.
Published: (2011)
Similar Items
-
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021) -
Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
by: V. V. Pushkarov, et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)